Searched for
VACCINE COMPETITION
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...- Plan in the works to let hospitals import med equipment directlyIndia's drug regulator is proposing to allow hospitals to directly import advanced medical equipment like MRI and CT scanners, bypassing cu...
- Fable 5 shock puts sovereign AI back on India’s agendaUS export controls on advanced AI models have spurred India's call for sovereign AI development. Industry leaders warn against reliance on ...
- To win the deep-tech race, India needs ‘General Innovation Rules’India is launching ambitious science initiatives. However, current financial rules designed for conventional procurement hinder R&D. A new ...
- Science at scale: India’s journey from food security to global leadershipToday, India is the world’s largest producer of milk, pulses, and spices; the largest exporter of rice; and among the leading producers of ...
- India, Oman trade pact to come into force from June 1; Check what's insideIndia and Oman's Comprehensive Economic Partnership Agreement, CEPA, begins on June 1. This pact offers Indian exports 100% duty-free acces...
- Tata 1mg turns Ebitda positive across core units as diagnostics crosses Rs 600 crore in ARRThe company said its diagnostics business crossed an annualised revenue run rate of more than Rs 600 crore during the year, growing over 40...
- Is Quad the Asian NATO or ocean foam? What Delhi meet revealsQuad foreign ministers met in Delhi focusing on practical cooperation. New initiatives target critical minerals, maritime surveillance, and...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Gen ex gets the gadgets, even if it means sometimes getting things tangled upBeneath the comedy of keeping up with the iJoneses lies the determination with which a generation is trying to keep up and stay tech-releva...
- Vivek Ramaswamy wins Republican nomination for Ohio governor after Trump's endorsementOhio voters have chosen their candidates for key November elections. Billionaire Vivek Ramaswamy will face Dr. Amy Acton for governor. Sena...
- Honesty and integrity were not enough: US-based entrepreneur Kal Somani-led group lashes Rajasthan Royals sale processA rival bidder has publicly questioned the Rajasthan Royals ownership sale process. The US-based entrepreneur Kal Somani and his partners e...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Gennova in talks with govt to price mRNA vaccine competitivelySince Gennova has the manufacturing-at-risk approval, it has already produced 7 million doses that have been released not only by the compa...
- Dr Reddy's Lab to approach regulator for Sputnik Light as universal booster doseThe Drugs Controller General of India (DCGI) in February granted approval to the single-shot Sputnik Light vaccine for restricted use in em...
- UK probes mega AstraZeneca deal for US biotech firmIn a brief statement, the Competition and Markets Authority said it was looking at whether the deal would "result in a substantial lessenin...
- China plays down its vaccine rivalry with IndiaChina welcomes more countries to produce effective vaccines to benefit more people, Chinese Foreign Ministry spokesman Zhao Lijiang told a ...
- Russia's Sputnik V COVID-19 vaccine will cost less than $20 per person internationallyThe pricing announcement comes as Russia looks to scale up distribution and production. Kirill Dmitriev, head of Russia's RDIF sovereign we...
- Competition Commission of India clears Novartis-GlaxoSmithKline pharma dealThe multi-layered deal involves UK-based GlaxoSmithKline acquiring Novartis's vaccine biz, while latter would purchase GSK's cancer drugs p...
Load More
